Zhang, R., Chang, R., Wang, H., Chen, J., Lu, C., Fan, K., . . . Dong, H. (2025). Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-024-80492-1
Chicago Style (17th ed.) CitationZhang, Ruijing, et al. "Untargeted Metabolomic and Proteomic Analysis Implicates SIRT2 as a Novel Therapeutic Target for Diabetic Nephropathy." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-024-80492-1.
MLA (9th ed.) CitationZhang, Ruijing, et al. "Untargeted Metabolomic and Proteomic Analysis Implicates SIRT2 as a Novel Therapeutic Target for Diabetic Nephropathy." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-024-80492-1.